GO2 Foundation for Lung Cancer points to targeted treatments and early screenings
Dr Andrew C. von Eschenbach receives James L. Mulshine, M.D. Leadership Award
UK Member funds cancer research by The University College London.
Spanish Association against Cancer meets PM Pedro Sánchez.
The firm’s liquid biopsy recorded a high success rate.
Our member in Italy to hold annual meeting.
The event will be in aid of the Tallaght Hospital, and the Irish Cancer Society.
The 13-strong committee will advise on cancer prevention and early detection.
American member announces exciting collaboration.
The event will focus on Lung Cancer and courage against all odds.
The event will include a Walk, Wag and Run Event, and their first Human and K-9 Walk/ Run.
The statement coincides with recent reports linking lung disease to vaping.
Patient in U.S dies of respiratory disease due to vaping.
Rebiopysing is important to check if treatment is effective.
The foundation has partnered up with the Belong App.
Christine Verini named as one of PharmaVOICE’s 100 most inspiring people.
It is hoped technology will improve screening effectiveness.
Every year more than 12,000 people die from Lung Cancer in the Netherlands.
The announcement follows World Lung Cancer day.
Imfinzi not as effective as hoped.
The event is a great chance to highlight Lung Cancer issues.
The money will fund vital research.
Results of a phase 1/ phase 2 trial are promising.
The prize will be awarded to the best publication focusing on Lung Cancer.
A vital tool offering accurate lung cancer data for every country.
12 patients attended to represent the amount of people who die from the disease per day.
The survey was carried out until the 1st of June by the Spanish Association for Lung Cancer Victims and the More Ideas Foundation.
The funding was announced on the 11th of June with support from the Stavros Niarchos Foundation.